{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-0308cd-2022-07-13T09:18:15+01:00", "date": "2022-07-13T09:18:15+01:00", "ocid": "ocds-h6vhtk-0308cd", "description": "TERMS AND CONDITIONS / ACTIVITY BASED INCOME (ABI) The terms and conditions of this Framework Agreement is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this Framework Agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE. SUBMISSION OF EXPRESSIONS OF INTEREST AND PROCUREMENT INFORMATION. This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: Register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk. Login to the portal with username/password. Click the SQs/ITTs Open to All Suppliers link. These are the SQs/ITTs open to any registered supplier. Click on the relevant SQs/ITT to access the content. Click the Express Interest button at the top of the page. This will move the SQs/ITT into your My SQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the SQs/ITT Details box. Follow the onscreen instructions to complete the SQs/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo e-Tendering Help Desk at help@bravosolution.co.uk. Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk. Please note that sid4gov does not prepopulate any fields of the SQ on HTE's Bravo Portal. Candidates must complete the Qualfication & Technical envelopes of the SQ on Bravo in full.", "initiationType": "tender", "tender": { "id": "SF051571", "legalBasis": { "id": "32014L0024", "scheme": "CELEX" }, "title": "Supply of Aseptically Prepared Dose Banded Medicines", "status": "complete", "classification": { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, "mainProcurementCategory": "goods", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "value": { "amount": 3500000000, "currency": "GBP" }, "lotDetails": { "awardCriteriaDetails": "one or more Lots" }, "lots": [ { "id": "1.1", "title": "BORTEZOMIB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.2", "title": "CARBOPLATIN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.3", "title": "CETUXIMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.4", "title": "CISPLATIN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.5", "title": "CYCLOPHOSPHAMIDE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.6", "title": "CYTARABINE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.7", "title": "DESFERRIOXAMINE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.8", "title": "DOCETAXEL", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.9", "title": "DOXORUBICIN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.10", "title": "EPIRUBICIN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.11", "title": "FLUOROURACIL", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.12", "title": "GANCICLOVIR", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.13", "title": "GEMCITABINE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.14", "title": "INFLIXIMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.15", "title": "IRINOTECAN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.16", "title": "METHOTREXATE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.17", "title": "NIVOLUMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.18", "title": "OXALIPLATIN", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.19", "title": "PACLITAXEL", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.20", "title": "PEMBROLIZUMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.21", "title": "PERTUZUMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.22", "title": "RITUXIMAB", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.23", "title": "TRASTUZUMAB SC", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.24", "title": "TRASTUZUMAB IV", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "1.25", "title": "VINCRISTINE", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 100000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "2", "title": "Aseptically Prepared Dose Banded Medicines", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 500000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "3", "title": "CIVAS (Centralised Intravenous Additive Service)", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 200000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" }, { "id": "4", "title": "Patient Specific Chemotherapy", "description": "The Tender is to establish a framework agreement for the supply of a range of aseptically prepared patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.", "awardCriteria": { "criteria": [ { "name": "Quality", "type": "quality", "description": "60%" }, { "name": "Price", "type": "cost", "description": "40%" } ] }, "value": { "amount": 300000000, "currency": "GBP" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Framework can be extended for up to a period of 24 months at HealthTrust Europe's discretion." }, "submissionTerms": { "variantPolicy": "notAllowed" }, "hasOptions": false, "status": "cancelled" } ], "items": [ { "id": "1.1", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.1" }, { "id": "1.2", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.2" }, { "id": "1.3", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.3" }, { "id": "1.4", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.4" }, { "id": "1.5", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.5" }, { "id": "1.6", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.6" }, { "id": "1.7", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.7" }, { "id": "1.8", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.8" }, { "id": "1.9", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.9" }, { "id": "1.10", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.10" }, { "id": "1.11", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.11" }, { "id": "1.12", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.12" }, { "id": "1.13", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.13" }, { "id": "1.14", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.14" }, { "id": "1.15", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.15" }, { "id": "1.16", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.16" }, { "id": "1.17", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.17" }, { "id": "1.18", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.18" }, { "id": "1.19", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.19" }, { "id": "1.20", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.20" }, { "id": "1.21", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.21" }, { "id": "1.22", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.22" }, { "id": "1.23", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.23" }, { "id": "1.24", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.24" }, { "id": "1.25", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33692000", "description": "Medical solutions" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "1.25" }, { "id": "2", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33680000", "description": "Pharmaceutical articles" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "2" }, { "id": "3", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33680000", "description": "Pharmaceutical articles" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "3" }, { "id": "4", "additionalClassifications": [ { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, { "scheme": "CPV", "id": "33680000", "description": "Pharmaceutical articles" }, { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "deliveryAddresses": [ { "region": "UK" }, { "region": "UK" } ], "relatedLot": "4" } ], "participationFees": [ { "id": "1", "type": [ "document" ] } ], "submissionMethod": [ "electronicSubmission", "written" ], "submissionMethodDetails": "https://healthtrusteurope.bravosolution.co.uk", "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "techniques": { "hasFrameworkAgreement": true }, "coveredBy": [ "GPA" ], "tenderPeriod": { "endDate": "2022-02-14T12:00:00Z" }, "submissionTerms": { "languages": [ "en" ] }, "awardPeriod": { "startDate": "2022-02-14T12:01:00Z" }, "bidOpening": { "date": "2022-02-14T12:01:00Z" }, "hasRecurrence": false }, "parties": [ { "id": "GB-FTS-1597", "name": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")", "identifier": { "legalName": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")" }, "address": { "streetAddress": "19 George Road", "locality": "Edgbaston, Birmingham", "region": "UK", "postalCode": "B15 1NU", "countryName": "United Kingdom" }, "contactPoint": { "telephone": "+44 08458875000", "email": "Neli.Raleva@htepg.com", "url": "https://healthtrusteurope.bravosolution.co.uk" }, "roles": [ "buyer" ], "details": { "url": "https://healthtrusteurope.bravosolution.co.uk", "classifications": [ { "scheme": "TED_CA_TYPE", "id": "BODY_PUBLIC", "description": "Body governed by public law" }, { "scheme": "COFOG", "id": "07", "description": "Health" } ] } }, { "id": "GB-FTS-29108", "name": "Legal Department", "identifier": { "legalName": "Legal Department" }, "address": { "streetAddress": "19 George Road", "locality": "Birmingham", "postalCode": "B15 1NU", "countryName": "United Kingdom" }, "roles": [ "mediationBody", "reviewContactPoint" ] }, { "id": "GB-FTS-58689", "name": "Qualasept Ltd t/a Bath ASU", "identifier": { "legalName": "Qualasept Ltd t/a Bath ASU" }, "address": { "locality": "Corsham", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-58690", "name": "Sciensus Pharma Services Ltd", "identifier": { "legalName": "Sciensus Pharma Services Ltd" }, "address": { "locality": "Burton-on-Trent", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-58691", "name": "Quantum Pharmaceutical Ltd", "identifier": { "legalName": "Quantum Pharmaceutical Ltd" }, "address": { "locality": "Durham", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-58692", "name": "Baxter Healthcare Limited", "identifier": { "legalName": "Baxter Healthcare Limited" }, "address": { "locality": "Newbury", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-58693", "name": "HealthTrust Europe", "identifier": { "legalName": "HealthTrust Europe" }, "address": { "streetAddress": "19 George Road", "locality": "Birmingham", "postalCode": "B15 1NU", "countryName": "United Kingdom" }, "roles": [ "reviewBody" ] } ], "buyer": { "id": "GB-FTS-1597", "name": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")" }, "language": "en", "awards": [ { "id": "019105-2022-1", "relatedLots": [ "3" ], "title": "Lot 3 - CIVAS (Centralised Intravenous Additive Service) - All Regions", "status": "active", "suppliers": [ { "id": "GB-FTS-58689", "name": "Qualasept Ltd t/a Bath ASU" } ] }, { "id": "019105-2022-2", "title": "Lot 1- Aseptically Prepared Dose Banded Medicines Committed Spend - West Midlands Region", "status": "active", "suppliers": [ { "id": "GB-FTS-58689", "name": "Qualasept Ltd t/a Bath ASU" }, { "id": "GB-FTS-58691", "name": "Quantum Pharmaceutical Ltd" }, { "id": "GB-FTS-58692", "name": "Baxter Healthcare Limited" } ] }, { "id": "019105-2022-3", "relatedLots": [ "2" ], "title": "Lot 2 - Aseptically Prepared Dose Banded Medicines - All Regions", "status": "active", "suppliers": [ { "id": "GB-FTS-58690", "name": "Sciensus Pharma Services Ltd" }, { "id": "GB-FTS-58692", "name": "Baxter Healthcare Limited" }, { "id": "GB-FTS-58689", "name": "Qualasept Ltd t/a Bath ASU" }, { "id": "GB-FTS-58691", "name": "Quantum Pharmaceutical Ltd" } ] } ], "contracts": [ { "id": "019105-2022-1", "awardID": "019105-2022-1", "title": "Lot 3 - CIVAS (Centralised Intravenous Additive Service) - All Regions", "status": "active", "value": { "amount": 200000000, "currency": "GBP" }, "dateSigned": "2022-07-01T00:00:00+01:00" }, { "id": "019105-2022-2", "awardID": "019105-2022-2", "title": "Lot 1- Aseptically Prepared Dose Banded Medicines Committed Spend - West Midlands Region", "status": "active", "value": { "amount": 100000000, "currency": "GBP" }, "dateSigned": "2022-07-01T00:00:00+01:00" }, { "id": "019105-2022-3", "awardID": "019105-2022-3", "title": "Lot 2 - Aseptically Prepared Dose Banded Medicines - All Regions", "status": "active", "value": { "amount": 500000000, "currency": "GBP" }, "dateSigned": "2022-07-01T00:00:00+01:00" } ], "bids": { "statistics": [ { "id": "1", "measure": "bids", "relatedLot": "3", "value": 1 }, { "id": "2", "measure": "bids", "value": 3 }, { "id": "3", "measure": "bids", "relatedLot": "2", "value": 4 } ] } }